Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers

INTRODUCTION: In vivo clinical, anatomical and metabolic differences between posterior cortical atrophy (PCA) patients presenting with different Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers profiles are still unknown. METHODS: Twenty-seven PCA patients underwent CSF examination...

Descripción completa

Detalles Bibliográficos
Autores principales: Montembeault, Maxime, Brambati, Simona M., Lamari, Foudil, Michon, Agnès, Samri, Dalila, Epelbaum, Stéphane, Lacomblez, Lucette, Lehéricy, Stéphane, Habert, Marie-Odile, Dubois, Bruno, Kas, Aurélie, Migliaccio, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197495/
https://www.ncbi.nlm.nih.gov/pubmed/30340200
http://dx.doi.org/10.1016/j.nicl.2018.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197495/
https://www.ncbi.nlm.nih.gov/pubmed/30340200
http://dx.doi.org/10.1016/j.nicl.2018.10.010

Ejemplares similares